The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells
about
Cas proteins: dodgy scaffolding in breast cancerThe Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cellsThe lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cellsMatrix crosslinking forces tumor progression by enhancing integrin signalingUnexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migrationTGF-beta-induced epithelial to mesenchymal transitionInhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cellsUXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenograftsLysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomasBlimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasisLysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.Lysyl oxidase, extracellular matrix remodeling and cancer metastasisBreast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.Lysyl oxidase in colorectal cancer.EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma.Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide.Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.Acquisition of the metastatic phenotype is accompanied by H2O2-dependent activation of the p130Cas signaling complexT3 affects expression of collagen I and collagen cross-linking in bone cell cultures.Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells.Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptideCharacterization of recombinant lysyl oxidase propeptide.Functional importance of lysyl oxidase family propeptide regions.Vascular smooth muscle cells direct extracellular dysregulation in aortic stiffening of hypertensive rats.
P2860
Q21146639-137D994C-91AA-4755-9681-9FF3DD51B522Q24301022-048046DE-C526-4DE1-B06D-85626CBA60F4Q24307235-85992E49-F3B3-447A-8A72-542A3922CD77Q24646370-119313A7-8CC5-4B9E-850C-55429E3A6B8CQ28565782-B78A7BF1-90B7-41FF-9C6E-D050DEFE444AQ29619820-05CEE810-4669-45BA-9B4E-FB4D63081463Q30009534-F2A1E80E-4E4C-4A00-B796-62EFB6B6106BQ30409213-AE4519ED-D671-47BD-8992-29B0E49C8F1EQ31138996-C7E2CC65-594C-4BCF-A14C-C58BFE804244Q33292171-04FADC8E-E7A6-498A-B846-54FF3ED7622CQ33748104-18D9C1EF-88AA-4FB2-9BA1-8DEDC6798C79Q34170606-5A1492D2-1005-4B4A-8915-722C1F557C0CQ34197948-B119DB97-9998-4CCA-9E9C-F565A18ED89AQ34206164-7861182D-E5B5-48D7-B998-88DB505477B1Q34355294-DB342F06-7C39-4287-A19D-F3778663A441Q34380963-E4145839-3A6A-4CF2-91B7-1B97172F4788Q34643236-5A11C41E-A6FA-4452-BB43-B60365FD038CQ34764399-7EE49727-CA54-4F5D-BC8A-BD11D74DA898Q36284915-78963FAD-7B4D-4B01-A5BA-6A68D5278311Q36736295-69885536-0371-4404-B52C-1A004083AC3DQ37312261-03F1FA4C-2933-464A-B395-F87098E83073Q37532942-100E9C4A-B6A4-48D5-B6F1-0C365AC45BD0Q38134562-14216030-57E4-4A9C-8C88-B904816F8CE8Q38563638-D1750F80-4468-4C7C-AF4F-35B6B001BC09Q38723997-0E29E53B-2BF0-419E-9532-C8AB5DBC6AF0Q38841862-BFC9E527-275E-4672-8313-8CAD989E1CF1Q38989588-14B4453D-2BDA-40C5-962E-61C274ED1134Q39205523-B811129C-4F54-4DF3-9478-B0C41DADACA7Q39667868-E105F9E6-325A-4ED7-AC82-594A7CE74ED2Q39702401-32FF196F-3E12-460C-AF77-5C67EDD1F63FQ39825713-01A649C8-23AC-4042-826F-F491E34E77F4Q40251892-7CBF962B-1CFC-4859-B7A5-A25F3F7E19F1Q41898229-710D868B-F71A-41C5-AE72-02CAB2EC2DAFQ42853848-D751ECE2-DC41-4463-BE25-BF586076A300Q47584936-1D1C2C1F-7D02-4C08-A14A-AD2D8CAA2572Q51758015-7A284AD5-A612-43DD-A11F-4647BD831CB4
P2860
The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The lysyl oxidase pro-peptide ...... p130Cas in breast cancer cells
@en
The lysyl oxidase pro-peptide ...... 130Cas in breast cancer cells.
@nl
type
label
The lysyl oxidase pro-peptide ...... p130Cas in breast cancer cells
@en
The lysyl oxidase pro-peptide ...... 130Cas in breast cancer cells.
@nl
prefLabel
The lysyl oxidase pro-peptide ...... p130Cas in breast cancer cells
@en
The lysyl oxidase pro-peptide ...... 130Cas in breast cancer cells.
@nl
P2093
P2860
P356
P1476
The lysyl oxidase pro-peptide ...... p130Cas in breast cancer cells
@en
P2093
Chengyin Min
Gail E Sonenshein
Siddharth R Vora
Yingshe Zhao
P2860
P304
P356
10.1074/JBC.M802612200
P407
P577
2008-11-21T00:00:00Z